Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Core Insights - Absci Corporation is a data-first generative AI drug creation company that will participate in the KeyBanc Capital Markets Healthcare Forum [1][2] - The company utilizes its Integrated Drug Creation™ platform to accelerate drug development and increase the probability of success by optimizing multiple drug characteristics [3] - Absci can screen billions of cells weekly, transitioning from AI-designed candidates to wet lab-validated candidates in as little as six weeks [3] Company Overview - Absci combines AI with scalable wet lab technologies to create biologics more efficiently for patients [3] - The company is headquartered in Vancouver, WA, with additional facilities in New York City and Zug, Switzerland [3] - Absci's investor relations website provides access to live and archived webcasts for interested parties [2]